Literature DB >> 20488227

Modulatory influence of stimulus parameters on optokinetic head-tracking response.

Biju B Thomas1, Dallas Shi, Kay Khine, Leo A Kim, Srinivas R Sadda.   

Abstract

Optokinetic testing is a non-invasive technique, widely used for visual functional evaluation in rodents. The modulatory influence of optokinetic stimulus parameters such as contrast level and grating speed on head-tracking response in normal and retinal degenerate (RD) mice (rd10) and rats (S334ter-line-3) was evaluated using a computer-based testing apparatus. In normal (non-RD) mice and rats, specific stripe width and grating speed was found to evoke maximum optokinetic head-tracking response. In line-3 RD rats, the contrast sensitivity loss was slow and remained close to the baseline (normal control) level until very late in the disease, whereas, in rd10 mice the progression of the contrast sensitivity loss was more rapid. Observed differences between rd10 mice and line-3 RD rats in the progression of contrast sensitivity loss may not be directly related to the degree of photoreceptor loss. In young RD mice, the modulatory influence of stimulus parameters on optokinetic head-tracking response was similar to normal control animals. During later stages, slower grating speed was required to evoke the maximum optokinetic response. Grating speed had lesser apparent influence on the response properties of line-3 RD rats. Discrepancies between the two RD models in the modulatory influence of optokinetic stimulus parameters can be the manifestation of fundamental species differences and/or differences in the degeneration pattern. This study highlights the importance of careful selection of appropriate stimulus parameters for testing optokinetic head-tracking response in RD animals. Copyright 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20488227      PMCID: PMC3995157          DOI: 10.1016/j.neulet.2010.05.031

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  16 in total

1.  Behavioral assessment of visual acuity in mice and rats.

Authors:  G T Prusky; P W West; R M Douglas
Journal:  Vision Res       Date:  2000       Impact factor: 1.886

Review 2.  Cell transplantation as a treatment for retinal disease.

Authors:  R D Lund; A S Kwan; D J Keegan; Y Sauvé; P J Coffey; J M Lawrence
Journal:  Prog Retin Eye Res       Date:  2001-07       Impact factor: 21.198

3.  Ganglion cell responses to retinal light stimulation in the absence of photoreceptor outer segments from retinal degenerate rodents.

Authors:  Gi-Jung An; Nobuya Asayama; Mark S Humayun; James Weiland; Jingtai Cao; Shang-Yeon Kim; Rhonda Grebe; Eugene de Juan; Srinivas Sadda
Journal:  Curr Eye Res       Date:  2002-01       Impact factor: 2.424

4.  Retinal transplantation-induced recovery of retinotectal visual function in a rodent model of retinitis pigmentosa.

Authors:  Botir T Sagdullaev; Robert B Aramant; Magdalene J Seiler; Gustaw Woch; Maureen A McCall
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-04       Impact factor: 4.799

5.  Visual functional effects of constant blue light in a retinal degenerate rat model.

Authors:  Biju B Thomas; Magdalene J Seiler; Robert B Aramant; Deedar Samant; Guanting Qiu; Neil Vyas; Shinichi Arai; Zhenhai Chen; SriniVas R Sadda
Journal:  Photochem Photobiol       Date:  2007 May-Jun       Impact factor: 3.421

Review 6.  Retinal degeneration mutants in the mouse.

Authors:  B Chang; N L Hawes; R E Hurd; M T Davisson; S Nusinowitz; J R Heckenlively
Journal:  Vision Res       Date:  2002-02       Impact factor: 1.886

7.  Presence of visual head tracking differentiates normal sighted from retinal degenerate mice.

Authors:  Caroline Thaung; Karen Arnold; Ian J Jackson; Peter J Coffey
Journal:  Neurosci Lett       Date:  2002-05-31       Impact factor: 3.046

8.  Optokinetic test to evaluate visual acuity of each eye independently.

Authors:  Biju B Thomas; Magdalene J Seiler; SriniVas R Sadda; Peter J Coffey; Robert B Aramant
Journal:  J Neurosci Methods       Date:  2004-09-30       Impact factor: 2.390

9.  Protection of visual functions by human neural progenitors in a rat model of retinal disease.

Authors:  David M Gamm; Shaomei Wang; Bin Lu; Sergei Girman; Toby Holmes; Nicholas Bischoff; Rebecca L Shearer; Yves Sauvé; Elizabeth Capowski; Clive N Svendsen; Raymond D Lund
Journal:  PLoS One       Date:  2007-03-28       Impact factor: 3.240

10.  Visual properties of transgenic rats harboring the channelrhodopsin-2 gene regulated by the thy-1.2 promoter.

Authors:  Hiroshi Tomita; Eriko Sugano; Yugo Fukazawa; Hitomi Isago; Yuka Sugiyama; Teru Hiroi; Toru Ishizuka; Hajime Mushiake; Megumi Kato; Masumi Hirabayashi; Ryuichi Shigemoto; Hiromu Yawo; Makoto Tamai
Journal:  PLoS One       Date:  2009-11-05       Impact factor: 3.240

View more
  11 in total

Review 1.  Cell replacement and visual restoration by retinal sheet transplants.

Authors:  Magdalene J Seiler; Robert B Aramant
Journal:  Prog Retin Eye Res       Date:  2012-07-05       Impact factor: 21.198

2.  Missing optomotor head-turning reflex in the DBA/2J mouse.

Authors:  Peter Barabas; Wei Huang; Hui Chen; Christopher L Koehler; Gareth Howell; Simon W M John; Ning Tian; René C Rentería; David Krizaj
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-08-29       Impact factor: 4.799

3.  Phenotypic characterization of P23H and S334ter rhodopsin transgenic rat models of inherited retinal degeneration.

Authors:  Matthew M LaVail; Shimpei Nishikawa; Roy H Steinberg; Muna I Naash; Jacque L Duncan; Nikolaus Trautmann; Michael T Matthes; Douglas Yasumura; Cathy Lau-Villacorta; Jeannie Chen; Ward M Peterson; Haidong Yang; John G Flannery
Journal:  Exp Eye Res       Date:  2017-11-06       Impact factor: 3.467

Review 4.  Psychophysical testing in rodent models of glaucomatous optic neuropathy.

Authors:  Stephanie L Grillo; Peter Koulen
Journal:  Exp Eye Res       Date:  2015-07-02       Impact factor: 3.467

5.  Discordant anatomical, electrophysiological, and visual behavioral profiles of retinal degeneration in rat models of retinal degenerative disease.

Authors:  Trevor J McGill; Glen T Prusky; Robert M Douglas; Douglas Yasumura; Michael T Matthes; Robert J Lowe; Jacque L Duncan; Haidong Yang; Kelly Ahern; Kate M Daniello; Byron Silver; Matthew M LaVail
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-09-14       Impact factor: 4.799

6.  Long-term evaluation of Leber's hereditary optic neuropathy-like symptoms in rotenone administered rats.

Authors:  Li Zhang; Laura Liu; Ann L Philip; Juan C Martinez; Juan C Guttierez; Mathieu Marella; Gaurav Patki; Akemi Matsuno-Yagi; Takao Yagi; Biju B Thomas
Journal:  Neurosci Lett       Date:  2014-12-03       Impact factor: 3.046

7.  Alternative complement pathway deficiency ameliorates chronic smoke-induced functional and morphological ocular injury.

Authors:  Alex Woodell; Beth Coughlin; Kannan Kunchithapautham; Sarah Casey; Tucker Williamson; W Drew Ferrell; Carl Atkinson; Bryan W Jones; Bärbel Rohrer
Journal:  PLoS One       Date:  2013-06-25       Impact factor: 3.240

Review 8.  Update on animal models of diabetic retinopathy: from molecular approaches to mice and higher mammals.

Authors:  Remya Robinson; Veluchamy A Barathi; Shyam S Chaurasia; Tien Y Wong; Timothy S Kern
Journal:  Dis Model Mech       Date:  2012-07       Impact factor: 5.758

Review 9.  Assessment of Safety and Functional Efficacy of Stem Cell-Based Therapeutic Approaches Using Retinal Degenerative Animal Models.

Authors:  Tai-Chi Lin; Magdalene J Seiler; Danhong Zhu; Paulo Falabella; David R Hinton; Dennis O Clegg; Mark S Humayun; Biju B Thomas
Journal:  Stem Cells Int       Date:  2017-08-27       Impact factor: 5.443

10.  Transplanted hESC-Derived Retina Organoid Sheets Differentiate, Integrate, and Improve Visual Function in Retinal Degenerate Rats.

Authors:  Bryce T McLelland; Bin Lin; Anuradha Mathur; Robert B Aramant; Biju B Thomas; Gabriel Nistor; Hans S Keirstead; Magdalene J Seiler
Journal:  Invest Ophthalmol Vis Sci       Date:  2018-05-01       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.